
Opinion|Videos|May 3, 2024
Overview of ESR1 Mutations in ER+/HER2- Metastatic Breast Cancer
Author(s)Stephanie L. Graff, MD
Stephanie L. Graff, MD, provides an overview of ESR1 mutations in ER+/HER2- metastatic breast cancer, highlighting their prevalence, clinical implications, and challenges.
Advertisement
Episodes in this series

Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Health Insurance CEOs Questioned by House Committee About Rising Costs in Health Care
2
By Improving Sleep, TNX-102 SL Reduces Pain and Fatigue in Fibromyalgia
3
FDA Draft Guidance Proposes CR, MRD to Accelerate MM Drug Approval
4
SGLT2 Inhibitors Linked to Lower Risk of CKD, AKI Than GLP-1 RAs
5





























































